Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study. Weighing risks and benefits of tamoxifen treatment for preventing breast cancer. Prospective validation of breast cancer risk model integrating classical risk-factors and polygenic risk in 15 cohorts and six countries. Polygenic risk scores for breast cancer and breast cancer subtypes. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Genetic risk, adherence to a healthy lifestyle, and coronary disease. Large uncertainty in individual PRS estimation impacts PRS-based risk stratification. Risk factors in coronary heart disease: the Framingham study. Improving reporting standards for polygenic scores in risk prediction studies. Evaluation of polygenic prediction methodology within a reference-standardized framework. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Genetic risk factors have substantial impact on healthy life years. Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality. The personal and clinical utility of polygenic risk scores. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Tread lightly interpreting polygenic tests of selection. Polygenic adaptation on height is overestimated due to uncorrected stratification in genome-wide association studies. Reduced signal for polygenic adaptation of height in UK Biobank. Penetrance and pleiotropy of polygenic risk scores for schizophrenia in 106,160 patients across four health care systems. Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Polygenic Risk Score Task Force of the International Common Disease Alliance. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample the EU-GEI study. Multi-polygenic score approach to trait prediction. Complex trait prediction from genome data: contrasting EBV in livestock to PRS in humans: genomic prediction.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |